Authors: Rosanna K. Martens, Chao Chen, David Ehmann, Mark Greve, Mark E. Seamone. Author Disclosure Block: R.K. Martens: None. C. Chen: None. D. Ehmann: None. M. Greve: None. M.E. Seamone: None.Purpose: To investigate the anatomic and visual outcomes of individuals undergoing pars plana vitrectomy (PPV) for uncomplicated, primary macula-off rhegmatogenous retinal detachment (RRD) with and without macular internal limiting...

At the end of this session participants will be able to:Demonstrate increased knowledge in the diagnosis and management of several infectious uveitis pathologies  Describe various retinal imaging findings in uveitis Describe various retinal imaging findings in uveitisCanMEDS Roles:Medical Expert, Scholar 

At the end of this session participants will be able to:• Demonstrate increased knowledge on the use of biosimilar agents and fluid analysis in the diagnosis and management of uveitis. • Integrate pearls on the management of ocular hypertension, postoperative inflammation in uveitis. CanMEDS Roles: Medical Expert, Scholar 

Learning ObjectivesAt the end of this session, participants will be able to:Assess and manage vitreoretinal lymphomaDescribe the choroidal changes in the treatment of diabetic retinopathyIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar 

Authors: Samir Touma, Andrei-Alexandru Szigiato, Fares Antaki, Simon Javidi, Renaud Duval, Ghassan Cordahi, Sebastien Olivier, Flavio Rezende. Author Disclosure Block: S. Touma: All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity; Name of for-profit or not-for-profit organization(s); Bayer Inc.. All other investments or...

Learning ObjectivesAt the end of this session, participants will be able to:Manage macular edema secondary to retinal vein occlusionDescribe management of peripapillary choroidal melanomasIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar

Learning ObjectivesAt the end of this session, participants will be able to:Describe prognostication for uveal melanomaApply real word data to the management of macular degeneration, diabetic macular edemaAssess patient experiences of inherited retinal diseasesCanMEDS Roles: Medical Expert, Scholar

Learning ObjectivesAt the end of this session, participants will be able to:Utilize OCT Imaging to differentiate various types of Pigmented Epithelial DetachmentsUtilize OCT Imaging of the choroid...

Objectifs d’apprentissage :À la fin de cette séance, les participants seront en mesure de faire ce qui suit:Comprendre les percées incroyables qui continuent d’être réalisées dans la prise en charge de la dégénérescence maculaire liée à l’âge.Savoir comment choisir la meil...

Author’s Name(s): Wai-Ching Lam, Timothy Lai, Xiaodong Sun, Shih-Jen Chen, Xin Zhang, Andrea Schulze, Tobias Machewitz, Min Zhao, Sergio LealAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Apellis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Novartis, Membership on an advisory panel, standing committee or board of directors, Amgen, Membership on an advi...

Author’s Name(s): Rajinder Nirwan, Robert L. Avery, Sara J. Haug, David Tabano, Gloria Chi, Manuel Amador, Aachal Kotecha, Philippe Margaron, Ming Yang Author’s Disclosure Block: Rajinder Nirwan: Roche, Employment/honoraria/consulting fees; Robert L. Avery: Consultant: Adverum, Alcon, Alimera, Allergan, Amgen, Apellis, AsclepiX, Bausch + Lomb, Cardinal, Clearside Biomedical, Coherus, EyePoint, Genentech, Inc., Helio Vision, InFocus Capital Partner...

Author’s Name(s): Mélanie Hébert, Valérie Gagné, Jean-Philippe Rozon, Serge Bourgault, Mathieu Caissie, Laurence Letartre, Éric Tourville, Ali DiraniAuthor’s Disclosure Block: Mélanie Hébert: Bayer, Grant/research support, Vision Health Research Network, Grant/research support, Fighting Blindness Canada, Grant/research support; Valérie Gagné: none; Jean-Philippe Rozon: none; Serge Bourgault: none; Mathieu Caissie: none; Laurence Letartre: none; Éric To...

Author’s Name(s): Reut Shor, Andrew Mihalache, Atefeh Noori, Renana Shor, Radha Kohly, Marko Popovic, Rajeev MuniAuthor’s Disclosure Block: Reut Shor, none; Andrew Mihalache, none; Atefeh Noori, none; Renana Shor, none; Radha Kohly, none; Marko Popovic, none; Rajeev Muni, noneAbstract BodyPurpose: To determine whether glucagon-like peptide-1 receptor agonist (GLP-1RA) use is associated with increased risk of developing neova...

Author’s Name(s): Andrew Mihalache, Ryan Huang, Marko Popovic, Sue Demian, Rajeev MuniAuthor’s Disclosure Block: Andrew Mihalache: none; Ryan Huang: none; Marko Popovic: Financial support (to institution) – PSI Foundation, Fighting Blindness Canada.; Sue Demian: none; Rajeev Muni: Consultant – Alcon, Apellis, AbbVie, Bayer, Bausch Health, Roche; Financial Support (to institution) – Alcon, AbbVie, Bayer, Novartis, Roche.Abstract Body

Author’s Name(s): Andrei-Alexandru Szigiato, Christiana Dinah, Francis Abreu, Pablo Arrisi, Aachal Kotecha, Ying Liu, Liliana Paris, Anne-Cecile Retiere, Jeffrey WillisAuthor’s Disclosure Block: Andrei-Alexandru Szigiato: Apellis, Employment/honoraria/consulting fees, Roche, Employment/honoraria/consulting fees; Christiana Dinah: Consultancy: AbbVie, Apellis, Boehringer Ingelheim, Janssen, Ora Clinical, Roche; Lecture fees: Apellis, Roche, Topcon; Inst...

Author’s Name(s): Bernard Hurley, Srinivas Sadda, Jennifer Lim, Yiyi Wang, Derrek Hibar, Andreas Maunz, Huanxiang Lu, Thomas Albrecht, Kara Gibson, Jeffrey Willis, Dolly ChangAuthor’s Disclosure Block: Bernard Hurley: Allergan, Employment/honoraria/consulting fees, Novartis, Employment/honoraria/consulting fees, Alcon Canada, Employment/honoraria/consulting fees, Bayer, Employment/honoraria/consulting fees, Roche, Employment/honoraria/consulting fees, ...

Author’s Name(s): Nirojini Sivachandran, Stela Vujosevic, Christiana Dinah, Roger Goldberg, Michael Ip, Ehsan Rahimy, Manuel Amador, Kara Gibson, Carl Glittenberg, Andreas MaunzAuthor’s Disclosure Block: Nirojini Sivachandran: Roche, Employment/honoraria/consulting fees, Bayer, Employment/honoraria/consulting fees, Apellis, Employment/honoraria/consulting fees; Stela Vujosevic: Consultant: AbbVie/Allergan, Apellis, Bayer, Boehringer Ingelheim, Novartis...

Author’s Name(s): Marko Popovic, Ryan Huang, Sumana Naidu, Andrew Mihalache, Peter Kertes, David Sarraf, SriniVas Sadda, Rajeev Muni, Radha KohlyAuthor’s Disclosure Block: Marko Popovic, none; Ryan Huang, none; Sumana Naidu, none; Andrew Mihalache, none; Peter Kertes, none; David Sarraf, none; SriniVas Sadda, none; Rajeev Muni, none; Radha Kohly, noneAbstract BodyPurpose: To investigate the sociodemographic and clinical fact...

Author’s Name(s): Parnian Arjmand, Ramin Khoramnia, Paolo Lanzetta, Anat Loewenstein, Michael Stewart, Richard Gale, Marion Munk, Ursula Schmidt-Ott, April McCullough, Claudia Tueckmantel, Alyson BerlinerAuthor’s Disclosure Block: Parnian Arjmand: Hoffman La Roche, Employment/honoraria/consulting fees, Bayer, Employment/honoraria/consulting fees, Apobiologix, Employment/honoraria/consulting fees, Young MDConnect, Employment/honoraria/consulting fees; R...

Author’s Name(s): Wai-Ching Lam, Shih-Jen Chen, Gemmy Cheung, Tomohiro Iida, Adrian Koh, Won Ki Lee, Paisan Ruamviboonsuk, Xiaodong Sun, Yasuo Yanagi, Timothy LaiAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Novartis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Amgen, Membership on an advisory panel, standing committee or board of directors, Apellis, ...

Author’s Name(s): Yosra Er-reguyeg, El Yazid Rhalem, Eunice Linh You, Anas Abu-Dieh, Mélanie Hébert, Huixin Zhang, Serge Bourgault, Mathieu Caissie, Éric Tourville, Ali DiraniAuthor’s Disclosure Block: Yosra Er-reguyeg: none; El Yazid Rhalem: none; Eunice Linh You: none; Anas Abu-Dieh: none; Mélanie Hébert: none; Huixin Zhang: none; Serge Bourgault: none; Mathieu Caissie: none; Éric Tourville: Department of Ophthalmology, Hospital Saint-Sacrement, Lava...

Author’s Name(s): Aurora Pecaku, Isabela Matins Melo, Rajeev MuniAuthor’s Disclosure Block: Aurora Pecaku, none; Isabela Matins Melo, none; Rajeev Muni, Silber Target FundAbstract BodyPurpose: To report the primary anatomic reattachment rate with pars plana vitrectomy-suprachoroidal viscopexy (VIT–SCVEXY) for rhegmatogenous retinal detachment (RRD) repair. Secondary outcomes included Snellen's visual acuity (VA) at postopera...

Author’s Name(s): Kirk Stephenson, Deepika Parameswarappa, Mark Seamone, Flavio Rizende, Cynthia Qian, Rajeev Muni, Peter Kertes, Ian MacDonald, Ajoy Vincent, Elise HeonAuthor’s Disclosure Block: Kirk Stephenson: Foundation Fighting Blindness Career Development / Clinical Research Fellowship Award, Grant/research support; Deepika Parameswarappa: none; Mark Seamone: none; Flavio Rizende: none; Cynthia Qian: none; Rajeev Muni: none; Peter Kertes: none; I...

Author’s Name(s): Lia Huo, Daniela Isaacs-Bernal, Ellie Monroe, Carter Teal, Thierry Léveillard, Shira Albeck, Tamar Unger, Valerie Wallace, Robert Fluhr, Anubhav Garg, Molly ShoichetAuthor’s Disclosure Block: Lia Huo, none; Daniela Isaacs-Bernal, none; Ellie Monroe, none; Carter Teal, none; Thierry Léveillard, none; Shira Albeck, none; Tamar Unger, none; Valerie Wallace, none; Robert Fluhr, none; Anubhav Garg, none; Molly Shoichet, none...

Author’s Name(s): Jennifer Ling, Kirk Stephenson, Olubayo Kolawole, Lica Chui, Cheryl Gregory-Evans, Kevin Gregory-Evans, Maryam Soleimani, Patrick MaAuthor’s Disclosure Block: Jennifer Ling, none; Kirk Stephenson, none; Olubayo Kolawole, none; Lica Chui, none; Cheryl Gregory-Evans, none; Kevin Gregory-Evans, none; Maryam Soleimani, none; Patrick Ma, noneAbstract BodyPurpose: To assess the effect of belzutifan, a first-in-cl...

 Objectifs d’apprentissage :À la fin de cette séance, les participants seront en mesure de faire ce qui suit:Comprendre le fonctionnement de la TCO à domicile et son application pratique...

Objectifs d’apprentissage : À la fin de cette séance, les participants seront en mesure de faire ce qui suit:Mettre en application les lignes directrices propres au Canada pour la détection de la rétinopathie du prématuré.

Objectifs d’apprentissage :À la fin de cette séance, les participants seront en mesure de faire ce qui suit:Évaluer les lignes directrices sur l’uvéite afin de déterminer à quel moment l’orientation vers un spécialiste de l’uvéite ...